医学
新生儿重症监护室
重症监护医学
限制
血小板输注
临床实习
病危
重症监护
输血
血小板
儿科
外科
机械工程
工程类
免疫学
家庭医学
作者
Antonio Del Vecchio,Caterina Franco,Flavia Petrillo,G. Damato
出处
期刊:American Journal of Perinatology
[Georg Thieme Verlag KG]
日期:2016-09-01
卷期号:33 (11): 1079-1084
被引量:20
标识
DOI:10.1055/s-0036-1586106
摘要
Based on small studies and not on statistically valid clinical trials, guidelines for neonatal transfusions remain controversial and practices vary greatly. Premature infants and critically ill neonates in the neonatal intensive care unit (NICU) often require blood transfusions and extremely preterm neonates receive at least one red blood cell transfusion during their hospital stay. Transfusions to neonates convey both benefits and risks and consequently it is imperative to establish specific guidelines to improve practice and avoid unnecessary transfusions. Appropriate and lifesaving platelet transfusion in thrombocytopenic bleeding neonates pertains to 2% of all neonates in NICUs. Inversely, 98% of platelet transfusions are given prophylactically, in the absence of bleeding, with the assumption that this reduces the risk of a serious hemorrhage. To date, no evidence base is available for assigning a platelet transfusion trigger to NICU patients. Each NICU should approve specific guidelines that best suit its local clinical practice. Therefore, whatever guidelines are chosen in deciding when to transfuse, what is most important is to adhere strictly to the guidelines adopted, thus limiting unnecessary transfusions that convey no benefits and carry both known and unknown risks.
科研通智能强力驱动
Strongly Powered by AbleSci AI